Travere Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Travere Therapeutics, Inc. will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025, at 8:15 a.m. PT, highlighting its commitment to addressing rare diseases [1] Group 1: Company Overview - Travere Therapeutics is a biopharmaceutical company focused on developing therapies for patients with rare diseases, emphasizing the urgent need for treatment options [2] - The company collaborates with the rare disease community to identify, develop, and deliver life-changing therapies, aiming to provide hope for patients and their families [2] Group 2: Event Details - Eric Dube, Ph.D., the president and CEO of Travere Therapeutics, will be the presenter at the upcoming healthcare conference [1] - A live webcast of the presentation will be available on the company's investor page, with a replay accessible for up to 30 days post-event [1]